Cheryl Zimberlin is a highly accomplished professional in the field of biotechnology, with extensive experience in venture capital, board memberships, and scientific research. She holds a Doctor of Philosophy in Biology from the renowned Academic Medical Center (Amc), a Bachelor of Science in Biology from Utrecht University, and a Master of Science in Biotechnology from Wageningen University & Research. Zimberlin has previously served in various leadership roles, including as a Principal and Associate at M Ventures, a board member at Vaximm Ag, Calypso Biotech, and Rewind Therapeutics, and a board observer at Apogen Biotechnologies and Macrophage Pharma.

Zimberlin's expertise lies in venture capital, scientific research, biotechnology, and board leadership. She has a deep understanding of the development and commercialization of innovative technologies in the life sciences industry. Her invaluable experience and knowledge have made her a sought-after advisor and consultant in the biotech sector.